Interestingly, the risk of infections seems only slightly increased in subjects with monogenic interferonopathies despite treatment with high doses JAKinhibs, probably because a complete inhibition of the IFN signaling is not achieved, as indicated by the little or partial reduction of the IFN score observed in treated patients [21,22]. This evidence concerns the gene IFNA1 and infection.